期刊文献+

芳姜黄酮衍生物对A375人黑素瘤细胞增殖及凋亡作用的机制研究 被引量:2

Effects of an ar-turmerone derivative on the proliferation and apoptosis of A375 human melanoma cells and their mechanisms
原文传递
导出
摘要 目的:研究一种芳姜黄酮衍生物(ATD)对人皮肤黑色素瘤A375细胞增殖及凋亡的影响。方法不同浓度(5、10、20、40、80μmol/L)ATD、长春新碱及芳姜黄酮体外作用A375及人皮肤成纤维细胞(HSF)48 h。CCK?8法检测细胞增殖抑制率;吖啶橙/溴化乙锭(AO/EB)染色,倒置显微镜观察细胞凋亡形态;DNA片段化检测细胞凋亡;比色法检测半胱氨酸天冬氨酸蛋白酶3(caspase?3)活性;流式细胞仪检测细胞凋亡及周期。结果ATD、长春新碱及芳姜黄酮对A375细胞有抑制增殖作用,且呈剂量依赖性(ATD:R2=0.99,F=340.96;长春新碱:R2=0.99,F=349.19;芳姜黄酮:R2=0.89,F=25.41,均P〈0.05),三者IC50分别为(15.96±0.02)、(77.00±0.04)及(356.95±0.01)μmol/L。当药物浓度为5μmol/L及10μmol/L时,ATD对HSF增殖抑制率分别为(8±0.06)%和(25±0.02)%,长春新碱为(33±0.04)%和(29±0.08)%,芳姜黄酮为(49±0.09)%和(34±0.07)%;ATD对A375细胞抑制率分别为(26±0.06)%和(39±0.02)%,长春新碱为(8±0.04)%和(17±0.08)%,芳姜黄酮为(6±0.09)%和(10±0.07)%,与二甲基亚砜相比,差异均有统计学意义(P<0.05),且ATD对A375细胞增殖抑制活性强于长春新碱及芳姜黄酮(P<0.05),但对HSF细胞毒性却明显低于长春新碱及芳姜黄酮(P<0.05)。ATD、长春新碱及芳姜黄酮均可诱导A375细胞凋亡,caspase?3活性随3种药物浓度增加而增强,且药效为ATD〉长春新碱〉芳姜黄酮。流式细胞仪检测证实,3种药物都能诱导细胞发生不同程度凋亡,同芳姜黄酮及长春新碱相比,ATD能显著诱导细胞凋亡,且以晚期凋亡为主。随药物浓度增加,ATD组G1期A375细胞逐渐增多,G2期及S期细胞数明显减少。结论 ATD对A375细胞有抑制增殖及促凋亡作用,该作用明显强于芳姜黄酮及长春新碱,其机制可能是激活caspase?3,使细胞周期阻滞在G1期,进而抑制肿瘤细胞分化与增殖。 Objective To investigate the effects of an ar?turmerone derivative(ATD)on the proliferation and apoptosis of A375 human melanoma cells. Methods Both A375 cells and human skin fibroblasts (HSFs) were cultured with different concentrations(5, 10, 20, 40 and 80μmol/L)of ATD, vincristine and ar?turmerone, separately, for 48 hours in vitro. Subsequently, cell counting kit?8 (CCK?8) was used to evaluate cell proliferation, inverted microscopy to observe cell morphology after acridine orange/ethidium bromide (AO/EB) staining, and a colorimetric method to estimate caspase?3 activity. DNA fragmentation assay and flow cytometry were performed to assess cell apoptosis, and flow cytometry was conducted to analyze cell cycle. Results ATD, vincristine and Ar?turmerone all inhibited the proliferation of A375 cells in a dose?dependent manner(ATD:R2=0.99, F=340.96, P〈0.05;vincristine:R2=0.99, F=349.19, P〈0.05;ar?turmerone:R2=0.89, F=25.41, P〈0.05). The fifty percent inhibitory concentra?tions(IC50s)of ATD, vincristine and ar?turmerone against A375 cells were 15.96 ± 0.02μmol/L, 77.00 ± 0.04μmol/L and 356.95 ± 0.01μmol/L respectively. When the drug concentrations were 5 and 10μmol/L, the proliferation of HSFs was inhibited by 8%± 0.06%and 25%± 0.02%respectively by ATD, by 49%± 0.09%and 34%± 0.07%respectively by ar?turmerone, and by 33%± 0.04%and 29%± 0.08%respectively by vincristine, and the proliferation of A375 cells was inhibited by 26%± 0.06%and 39%± 0.02%respectively by ATD, by 6%± 0.09%and 10%± 0.07%respectively by ar?turmerone, and by 8% ± 0.04% and 17% ± 0.08% respectively by vincristine, with the inhibitory effects of the three drugs being significantly different from that of dimethyl sulfoxide(all P〈0.05). ATD showed stronger inhibitory effects on the proliferation of A375 cells, but weaker cytotoxic effects on HSFs compared with ar?turmerone and vincristine(all P〈0.05). Meanwhile, ATD, vincristine and ar?turmerone all induced the apoptosis of A375 cells(P〈0.05), and caspase?3 activity increased with the increase in drug concentrations(ATD:R2=0.98, F=162.30, P〈0.05;vincristine:R2=0.96, F=94.39, P〈0.05;ar?turmerone:R2=0.95, F=57.35, P〈0.05). The effect of ATD on caspase?3 activity was strongest, followed by that of vincristine and ar?turmerone. As flow cytometry showed, all the three drugs induced cell apoptosis to different degrees, and ATD showed a relatively strong effect on cell apoptosis, especially late apoptosis, compared with the other two drugs. In the ATD group, the number of A375 cells in G1 phase gradually increased, while that in G2 phase and S phase significantly decreased with the increase in drug concentrations. Conclusions ATD exhibited proliferation?inhibiting and apoptosis?inducing effects on A375 cells, and the effects were stronger than those of vincristine and ar?turmerone. It is quite possible that ATD affects cell proliferation and differentiation by activating caspase?3 and arresting cell cycle in the G1 phase.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2016年第7期489-494,共6页 Chinese Journal of Dermatology
基金 基金项目:贵州省中药现代化专项项目[黔科合中药字(2012)5018号] 贵阳市科技局科技创新平台项目[筑科合同(2012303)号] 贵州省中药民族药创制工程中心[黔教合字(2012)018号]
关键词 黑色素瘤 实验性 细胞系 肿瘤 姜黄酮 长春新碱 细胞增殖 细胞凋亡 芳姜黄酮衍生物 Melanoma,experimental Cell line,tumor Turmerone Vincristine Cell proliferation Apoptosis Ar-turmerone derivatives
  • 相关文献

参考文献3

二级参考文献41

  • 1黄继汉,黄晓晖,陈志扬,郑青山,孙瑞元.药理试验中动物间和动物与人体间的等效剂量换算[J].中国临床药理学与治疗学,2004,9(9):1069-1072. 被引量:1319
  • 2陈铁晖,严国鸿,陈华.姜黄的化学成分及抗肿瘤作用研究进展[J].海峡预防医学杂志,2004,10(6):23-25. 被引量:25
  • 3孙秀燕,李秀琴,王金辉,赵春超,刘珂.姜黄挥发油抗癌活性成分研究[J].中草药,2006,37(7):982-983. 被引量:25
  • 4ALANO CC,GARNIER P,YING W, et al. NAD ^+ depletion is necessary and sufficient for poly (ADP-ribose) polymer- ase-1-mediated neuronal death [ J ]. Neurosci, 2010, 30 (8) :2967 - 2978.
  • 5ANDRABI SA, KIM NS, YU SW,et al. Poly(ADP-ribose) (PAR) polymer is a death signal [ J ]. Proceedings of the National Academy of Sciences of the United States of Amer- ica, 2006,103 (48) : 18308 - 18313.
  • 6MEHTA SL, MANHAS N, RAGHUBIR R. Molecular tar- gets in cerebral ischemia for developing novel therapeutics [ J ]. Brain Research Reviews, 2007,54 ( 1 ) : 34 - 66.
  • 7SAIRANEN T, SZEPESI R, KARJALAINEN-LINDS- BERG ML, et al. Neuronal easpase-3 and PARP-1 corre- late differentially with apoptosis and necrosis in ischemic human stroke [ J ]. Acta Neuropathol, 2009, 118 ( 4 ) : 541 - 552.
  • 8SIEGEL C, MCCULLOUGH LD. NAD + depletion or PAR polymer formation: which plays the role of executioner in isehaemie cell death [ J ]. Aeta Physiol, 2011,203 ( 1 ) : 225 - 234.
  • 9BROUGHTON BR, REUTENS DC, SOBEY CG. Apoptot- ic mechanisms after cerebral ischemia [ J ]. Stroke, 2009, 40 :e331 - e339.
  • 10KIM J, KIM HY, LEE SM. Protective Effects of Genipo- side and Genipin against Hepatic Ischemia/Reperfusion Injury in Mice [ J]. Biomol Ther, 2013, 21 (2): 132 - 137.

共引文献34

同被引文献11

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部